Recent MBIO News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/05/2026 08:01:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/27/2026 08:05:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/17/2026 08:01:34 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/19/2026 08:05:32 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 01/05/2026 10:00:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/30/2025 09:15:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/23/2025 09:05:15 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/03/2025 09:05:40 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2025 09:06:17 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/05/2025 08:01:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2025 08:05:51 PM
- Mustang Bio Shares Surge After FDA Grants Orphan Drug Status • IH Market News • 07/07/2025 01:29:52 PM
- Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma • GlobeNewswire Inc. • 07/07/2025 12:30:55 PM
